awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33398716-F44E3D9E-E1AE-4DB6-9AD5-DFF320F9E719
Q33398716-F44E3D9E-E1AE-4DB6-9AD5-DFF320F9E719
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398716-F44E3D9E-E1AE-4DB6-9AD5-DFF320F9E719
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).
P2860
Q33398716-F44E3D9E-E1AE-4DB6-9AD5-DFF320F9E719
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398716-F44E3D9E-E1AE-4DB6-9AD5-DFF320F9E719
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70ea8e210af34c6411d5127994a1b7f507d6f4ac
P2860
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency